This message is sent to you by FDA Newswatch

Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do

Thursday, 12 October 2017  10:00 AM PDT, 01:00 PM EDT

Training Duration = 60 Min                    Sponsored by Online Compliance Panel

Click Here to register $200.00

Click Here to register and receive CD recording $400.00

The Anti-Kickback Statute is so broad in what it proscribes, healthcare organizations, conducting what would be normal marketing activities in other industries, have run afoul of the statute on numerous occasions. The Statute and the regulations only tell part of the story.

This webinar will review not only the Anti-Kickback Statute and its safe harbors, but will provide an in-depth overview of OIG guidance and advisory opinions dealing with marketing activities, as well as a review of case law regarding marketing behavior.

To understand the implications of the federal fraud and abuse laws, and particularly the Anti-Kickback Statute, as they relate to healthcare marketing.

Learning Objectives:

To understand the implications of the federal fraud and abuse laws, and particularly the Anti-Kickback Statute, as they relate to healthcare marketing.

Why Should You Attend:

If your organization, be it a hospital, physician practice, DME provider, or any other provider offering healthcare services or supplies, engages in marketing its product or services, care must be taken to ensure that the organization does not run afoul of the Anti-Kickback Statute.

This program will review not only the Statute itself, and the safe harbours, but will also critique the case law, OIG advisory opinions, and OIG compliance guidance to help you understand what you can and cannot do with engaging in healthcare marketing.

When you finish this program, you should have a good understanding of what you can and cannot do with regard to marketing activities. The penalties for not conducting a marketing program correctly can be severe, including exclusion, civil monetary penalties and even criminal prosecution.

Topics

  • A brief review of the Anti-Kickback Statute, what it is and what is prohibited
  • A brief review of the safe harbors that relate to marketing activities
  • A review of the OIG advisory opinions as they relate to marketing
  • A review of OIG compliance guidance as it relates to marketing
  • An overview of case law relating to marketing activities
  • Strategies that should be taken to preclude liability

Instructor

William Mack Copeland, MS, JD, PhD, LFACHE, practices health care law in Cincinnati at the firm of Copeland Law, LLC, where he is the president and the CEO. He is also the president of the Executive & Managerial Development Group, a consulting entity providing compliance and other fraud and abuse related services.

A graduate of Northern Kentucky University Salmon P. Chase College of Law, Bill is a frequent author and speaker on health law topics. He is a member of the American Health Lawyers Association, American, Ohio and Cincinnati Bar Associations. A former hospital chief executive officer, he is a life fellow in the American College of Healthcare Executives.

He was awarded the American College of Health Care Executives Senior-Level Healthcare Executive Regent's Award in 2007.